ExxonMobil Commits New Funds for Malaria Research and Capacity Building
27 Septembre 2005 - 6:42PM
Business Wire
ExxonMobil today announced more than $1.5 million in new grants to
help fight malaria in Africa. As a business with major African oil
and gas exploration and production, retail marketing and
distribution activities, ExxonMobil has long been aware of the
devastating impact of malaria on the continent. "We established our
Africa Health Initiative in 2000 because we strongly believe that
improvements in public health can be a basis for broader economic
and social gains. Since then we have dedicated more than $11.5
million to community activities related to the prevention, control
and treatment of malaria in Africa," said Rex Tillerson, president,
Exxon Mobil Corporation (NYSE:XOM). The public-private partnerships
announced today specifically focus on vaccine development and
supporting African health practitioners and researchers in their
efforts to prevent, diagnose, treat and control malaria. "Malaria
is a disease that is preventable, treatable and curable, yet kills
one million people every year. Grants for training and research,
such as those announced today, are core to our strategy to find
long-term solutions and help communities help themselves," said
Susan Carter, manager, Global Community Relations, Exxon Mobil
Corporation. The Academic Alliance Foundation has received $500,000
to support the development of a malaria program within the
curriculum of the Infectious Diseases Institute at Makerere
University in Kampala, Uganda. The Institute runs a variety of
teaching programs, training pan-African health-care providers with
the latest tools and techniques to deliver high quality care in the
area of infectious diseases and have the capability to train
others. "This grant will enable us to vastly expand our infectious
diseases training activities," said Dr. Merle A. Sande, president
of AAF. "By providing expertise to local scientists and physicians,
who promote the development of new, innovative and practical
interventions to prevent, treat and control the malaria epidemic,
ExxonMobil's partnership with AAF focuses on building the next
generation of medical leadership in sub-Saharan Africa." The PATH
Malaria Vaccine Initiative has received $500,000 to support
advocacy for malaria vaccine development, a malaria vaccine
technology roadmap, and malaria vaccine market assessment. The MVI
exists to help ensure that there will be a malaria vaccine in the
shortest timeframe possible. Its mission is to accelerate the
development of promising vaccines and ensure their availability and
accessibility to the developing world. "The PATH Malaria Vaccine
Initiative (MVI) is focused on moving vaccine candidates rapidly
through the development pipeline. ExxonMobil's funding, together
with that of our other partners, helps to ensure the necessary
investment in research and development critical to finding a
vaccine to help end deaths from malaria," noted Dr. Melinda Moree,
director of MVI. The World Health Organization Programme for
Research and Training in Tropical Diseases has received $500,000.
TDR, the training and capacity building arm of the Multilateral
Initiative for Malaria, will use these funds to help foster the
development of human resources and research infrastructure for
fighting malaria in Africa. "Research is critical not only to
developing new tools, but to identifying the most effective ways to
implement current treatments," says Dr. Robert G. Ridley, director
of TDR. "ExxonMobil's support will allow us to expand our
collaboration with the Multilateral Initiative on Malaria on
research to inform anti-malarial drug policies, effective use of
insecticide-treated bed nets and research and development into new
control tools so critically needed in Africa." -0- *T ExxonMobil
Africa Health Initiative Additional Grants Made in 2005 include:
Academy for Educational Development / Netmark: To run the
successful 'Help Us Help' campaign in Cameroon, Ghana, Kenya and
Zambia. The campaign teaches preventative actions and distributes
discount vouchers for long-lasting insecticide-treated bednets to
pregnant women. Africare: For community based malaria intervention
and early treatment in Angola (particularly focused on refugees and
internally displaced persons). The project includes community
education on prevention and case management, volunteer training,
and the provision of anti-malarial drugs and literature. American
Red Cross: For bednet distribution in conjunction with national
measles vaccination campaigns in Equatorial Guinea and Chad. Every
adult who accompanies a child under five years to the vaccination
post will receive a free bednet. Harvard Malaria Initiative: To
research the mechanisms and genomics of the African malaria
parasite, to identify novel drug targets and to train African
scientists in anti-malarial drug techniques. Medicines for Malaria
Venture: To support the development and discovery of new malaria
drugs. Medisend International: For the supply of medical, surgical,
diagnostic and therapeutic medical supplies and equipment to
hospitals in need in Nigeria and Equatorial Guinea. MENTOR (Malaria
Emergency Technical and Operational Support): To build the capacity
of Angolan emergency health providers by disseminating and
developing standardized use of Roll Back Malaria best practice in
malaria prevention, diagnosis and case management. Population
Services International (PSI): For social marketing of long lasting
insecticide-treated bednets in Angola and Cameroon. Project Hope:
For a 'Village Health Bank' pilot program in Mozambique. The
program will combine micro-credit lending with health education.
Safe Blood for Africa: For the continuation of efforts (training,
testing, equipment) to ensure a disease-free blood supply in
Nigeria. Centre de Support en Sante Internationale de Institut
Tropical Suisse au Tchad: For the rehabilitation of the Kome Health
Clinic in Chad. UN Foundation: AFRICA LIVE, the Roll Back Malaria
Concert featuring Youssou N'Dour, Senegal, March 2005. World
Economic Forum - Global Health Initiative: To support the
establishment of technical standards for workplace malaria
management, create advocacy materials and negotiate public-private
partnerships. *T
Exxon Mobil (NYSE:XOM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Exxon Mobil (NYSE:XOM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024